Correlation Between Aridis Pharmaceuticals and ABVC Biopharma

Can any of the company-specific risk be diversified away by investing in both Aridis Pharmaceuticals and ABVC Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aridis Pharmaceuticals and ABVC Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aridis Pharmaceuticals and ABVC Biopharma, you can compare the effects of market volatilities on Aridis Pharmaceuticals and ABVC Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aridis Pharmaceuticals with a short position of ABVC Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aridis Pharmaceuticals and ABVC Biopharma.

Diversification Opportunities for Aridis Pharmaceuticals and ABVC Biopharma

-0.38

Correlation Coefficient

Aridis Pharmaceuticals  ABVC Biopharma

Very good diversification

The 3 months correlation between Aridis and ABVC is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Aridis Pharmaceuticals and ABVC Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ABVC Biopharma and Aridis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aridis Pharmaceuticals are associated (or correlated) with ABVC Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ABVC Biopharma has no effect on the direction of Aridis Pharmaceuticals i.e., Aridis Pharmaceuticals and ABVC Biopharma go up and down completely randomly.

Pair Corralation between Aridis Pharmaceuticals and ABVC Biopharma

If you would invest  27.00  in Aridis Pharmaceuticals on October 25, 2024 and sell it today you would earn a total of  0.00  from holding Aridis Pharmaceuticals or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	1.69%
Values	Daily Returns

Aridis Pharmaceuticals  vs.  ABVC Biopharma

Aridis Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Aridis Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Aridis Pharmaceuticals is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

ABVC Biopharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days ABVC Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Aridis Pharmaceuticals and ABVC Biopharma

The main advantage of trading using opposite Aridis Pharmaceuticals and ABVC Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aridis Pharmaceuticals position performs unexpectedly, ABVC Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ABVC Biopharma will offset losses from the drop in ABVC Biopharma's long position.

The idea behind Aridis Pharmaceuticals and ABVC Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.